New at CADTH — April 2022

Corporate News and Events

CADTH Releases Its Annual List of Health Technology Trends to Watch
CADTH’s 2022 Health Technology Trends to Watch report is an evidence-informed watch list that identifies and assesses emerging health technology trends and their implications. CADTH produced the report as part of its horizon scanning program, which alerts decision-makers to potentially high-impact health technologies and helps them prepare for future needs or implementation considerations.

CADTH Expert and Advisory Committees Call for Nominations
Our experts need your expertise. CADTH is seeking nominations to our expert and advisory committees. We’re looking for 16 individuals with significant expertise in the Canadian health care system to join various committees. Deadline to submit nominations is April 25, 2022.

Consultations on 2 Proposals to Help Enhance Drug Review Processes
CADTH has launched consultations on a proposed process for non-sponsored reimbursement reviews and a streamlined process for drug class reviews. Submit feedback by April 14. Learn more.

CADTH Reports and Recommendations

Reimbursement Reviews

Drug funding recommendations for Canada's federal, provincial, and territorial public drug programs. Reimbursement recommendations are based on comprehensive assessments of the clinical and pharmacoeconomic evidence, as well as input from pharmaceutical companies, clinicians, and patient groups.

• tralokinumab (Adtralza) for atopic dermatitis
• colchicine (Myinfla) for atherothrombotic events in coronary artery disease
• somatrogon (Ngenla) for growth hormone deficiency
• trientine hydrochloride (Waymade-Trientine) for Wilson disease
• estradiol and progesterone (Bijuva) for vasomotor symptoms associated with menopause
• ravulizumab (Ultomiris) for paroxysmal nocturnal hemoglobinuria
• nivolumab (Opdivo) for gastroesophageal junction or esophageal adenocarcinoma
• cemiplimab (Libtayo) for basal cell carcinoma

CADTH Horizon Scans

Information about new and emerging health technologies that could impact the delivery of care in Canada.

• Emerging Drugs for Amyotrophic Lateral Sclerosis
• Electrospun Healing Fibres for the Management of Burns and Wounds
• Artificial Intelligence for the Prediction of Sepsis in Adults
• Vacuum-Induced Uterine Tamponade for Postpartum Hemorrhage
• 2022 Health Technology Trends to Watch

CADTH Health Technology Reviews

Independent assessments of health technologies. Assessments consist of 1, or a combination, of the following: an environmental scan, a rapid review, a clinical (or systematic) review, an economic review, and a review of patient perspectives. They may also include an assessment of the legal, ethical, social, implementation, environmental, and policy implications of the health technology. Recommendations on the appropriate use of health technologies are provided where applicable.

• Vitamin B12 Testing in People With Suspected Vitamin B12 Deficiency — Rapid Review
• Folate Testing in People With Suspected Folate Deficiency – Rapid Review
• Robotic-Assisted Surgical Systems for Knee Arthroplasty – Rapid Review
• Adalimumab for the Treatment of Pediatric Populations With Non-Infectious Uveitis – Rapid Review
• PET-CT Exam Volumes: Comparison of Canada With Other Countries

CADTH Reference Lists

Lists of the publicly available and grey literature that identify the available evidence and the gaps in the scientific literature.

• Experiences of Models of Chronic Pain Care: A Qualitative Review
• Medication Administration by Health Care Aides in Long-Term Care Facilities
• Maximum Blood Draw for Pediatric Patients

Other CADTH Tools

• Hospital News article: Tuberculosis: A pandemic overshadowed by another pandemic
• In Brief: Intraocular Lenses for Infants With Aphakia 

Tell Us What You Think

We love hearing how our products and services are influencing health care policies, clinical practices, and patient outcomes. If you have a success story to share, please get in touch with your CADTH Liaison Officer.

CADTH E-Alerts : Subscribe to receive the latest CADTH news, reports, feedback opportunities, and events.